Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy.

Author(s):  
H Hisatomi ◽  
K Nagao ◽  
T Kanamaru ◽  
H Endo ◽  
M Tomimatsu ◽  
...  
2000 ◽  
Vol 82 (5) ◽  
pp. 1051-1057 ◽  
Author(s):  
K Dhaene ◽  
G Vancoillie ◽  
J Lambert ◽  
J M Naeyaert ◽  
E Van Marck

2000 ◽  
Vol 88 (6) ◽  
pp. 895-901 ◽  
Author(s):  
Maria Laura Falchetti ◽  
Roberto Pallini ◽  
Ettore D'Ambrosio ◽  
Francesco Pierconti ◽  
Maurizio Martini ◽  
...  

2006 ◽  
Vol 17 (4) ◽  
pp. 387-398 ◽  
Author(s):  
Zuojie Luo ◽  
Jianling Li ◽  
Yinfen Qin ◽  
Yan Ma ◽  
Xinghuan Liang ◽  
...  

Oncogene ◽  
1999 ◽  
Vol 18 (6) ◽  
pp. 1361-1368 ◽  
Author(s):  
Anne M Galloway ◽  
Charlotte A Spencer ◽  
Carl W Anderson ◽  
M Joan Allalunis-Turner

2001 ◽  
Vol 281 (4) ◽  
pp. E713-E725 ◽  
Author(s):  
Lauri A. Hornbuckle ◽  
Dale S. Edgerton ◽  
Julio E. Ayala ◽  
Christina A. Svitek ◽  
James K. Oeser ◽  
...  

The regulation of glucose-6-phosphatase (G-6-Pase) catalytic subunit and glucose 6-phosphate (G-6- P) transporter gene expression by insulin in conscious dogs in vivo and in tissue culture cells in situ were compared. In pancreatic-clamped, euglycemic conscious dogs, a 5-h period of hypoinsulinemia led to a marked increase in hepatic G-6-Pase catalytic subunit mRNA; however, G-6 -P transporter mRNA was unchanged. In contrast, a 5-h period of hyperinsulinemia resulted in a suppression of both G-6-Pase catalytic subunit and G-6 -P transporter gene expression. Similarly, insulin suppressed G-6-Pase catalytic subunit and G-6 -P transporter gene expression in H4IIE hepatoma cells. However, the magnitude of the insulin effect was much greater on G-6-Pase catalytic subunit gene expression and was manifested more rapidly. Furthermore, cAMP stimulated G-6-Pase catalytic subunit expression in H4IIE cells and in primary hepatocytes but had no effect on G-6 -P transporter expression. These results suggest that the relative control strengths of the G-6-Pase catalytic subunit and G-6 -P transporter in the G-6-Pase reaction are likely to vary depending on the in vivo environment.


2004 ◽  
Vol 286 (5) ◽  
pp. E795-E808 ◽  
Author(s):  
Lauri A. Hornbuckle ◽  
Carrie A. Everett ◽  
Cyrus C. Martin ◽  
Stephanie S. Gustavson ◽  
Christina A. Svitek ◽  
...  

We recently compared the regulation of glucose-6-phosphatase (G-6-Pase) catalytic subunit and glucose 6-phosphate (G-6- P) transporter gene expression by insulin in conscious dogs in vivo (Hornbuckle LA, Edgerton DS, Ayala JE, Svitek CA, Neal DW, Cardin S, Cherrington AD, and O'Brien RM. Am J Physiol Endocrinol Metab 281: E713–E725, 2001). In pancreatic-clamped, euglycemic conscious dogs, a 5-h period of hypoinsulinemia led to a marked increase in hepatic G-6-Pase catalytic subunit mRNA; however, G-6- P transporter mRNA was unchanged. Here, we demonstrate, again using pancreatic-clamped, conscious dogs, that glucagon is a candidate for the factor responsible for this selective induction. Thus glucagon stimulated G-6-Pase catalytic subunit but not G-6- P transporter gene expression in vivo. Furthermore, cAMP stimulated endogenous G-6-Pase catalytic subunit gene expression in HepG2 cells but had no effect on G-6- P transporter gene expression. The cAMP response element (CRE) that mediates this induction was identified through transient transfection of HepG2 cells with G-6-Pase catalytic subunit-chloramphenicol acetyltransferase fusion genes. Gel retardation assays demonstrate that this CRE binds several transcription factors including CRE-binding protein and CCAAT enhancer-binding protein.


Sign in / Sign up

Export Citation Format

Share Document